OncoSignal

Kazuoki Kondo

Tanabe Pharma Corporation · Mitsubihsi Tanabe Pharma Corporation

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official
32
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
193
PubMed author-name match

Trials

Studies that name Kazuoki Kondo as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:10 UTC. Open this list on ClinicalTrials.gov

Grants

NIH projects from RePORTER, fetched 2026-11-12 01:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:10 UTC. The ranking covers the 200 most relevant of 193 PubMed records, and a shared surname and initials can bring in a namesake. All 193 on PubMed

  1. 2,656 citations
    RCR 153.2
  2. 1,556 citations
    RCR 88.3
  3. 1,050 citations
    RCR 71.3
  4. 401 citations
    RCR 26.2
  5. 287 citations
    RCR 9.8
  6. 159 citations
    RCR 5.8
  7. 154 citations
    RCR 4.4
  8. 151 citations
    RCR 4.9
  9. 120 citations
    RCR 4.0
  10. 115 citations
    RCR 4.5